You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 282 No. 21, December 1, 1999 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Contempo 1999: Updates Linking Evidence and Experience
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (36)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA

Chlamydia pneumoniae and Atherosclerosis

Allan Shor, MMed; James I. Phillips, PhD

JAMA. 1999;282:2071-2073.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Atherosclerosis is a major cause of stroke, coronary heart disease, peripheral vascular disease, and aortic aneurysm. Because of the prevalence and importance of these diseases, atherosclerotic lesions within arteries have been extensively studied.1-2 While many risk factors have been identified,1-2 the mechanism by which the lesions are formed remains unknown. The most popular concept is that the endothelium lining the lumen of the artery becomes damaged. This damage alters the properties of the endothelium and leads to a cascade of events culminating in fibrosis, necrosis, lipid accumulation, and eventually calcification. There have been several candidates forwarded as putative initiators of endothelial injury including microorganisms.1 Recent studies have shown an association between an obligate intracellular bacterium, Chlamydia pneumoniae, and atherosclerosis.3-4

Chlamydia pneumoniae was first described by Grayston et al5 in 1986. Seroepidemiological studies have concluded that the majority of the population has been . . . [Full Text of this Article]

Author Affiliations: National Centre for Occupational Health (Drs Shor and Phillips) and South African Institute for Medical Research, School of Pathology, University of the Witwatersrand, (Dr Shor) Johannesburg, South Africa.


RELATED ARTICLE

December 1, 1999
JAMA. 1999;282(21):2087-2088.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Chlamydophila pneumoniae and Endothelial Activation: The Smoke That Precedes the Fire of Atherosclerosis?
Didion
Circ. Res. 2008;102:861-863.
FULL TEXT  

Body mass index and mortality from ischaemic heart disease in a lean population: 10 year prospective study of 220 000 adult men
Chen et al.
Int J Epidemiol 2006;35:141-150.
ABSTRACT | FULL TEXT  

Toll-Like Receptor 2 Mediates Persistent Chemokine Release by Chlamydia pneumoniae-Infected Vascular Smooth Muscle Cells
Yang et al.
Arterioscler. Thromb. Vasc. Bio. 2005;25:2308-2314.
ABSTRACT | FULL TEXT  

Exposure to Chlamydia pneumoniae Infection and Progression of Age-related Macular Degeneration
Robman et al.
Am J Epidemiol 2005;161:1013-1019.
ABSTRACT | FULL TEXT  

Potential Role of Endotoxin as a Proinflammatory Mediator of Atherosclerosis
Stoll et al.
Arterioscler. Thromb. Vasc. Bio. 2004;24:2227-2236.
ABSTRACT | FULL TEXT  

Chlamydia pneumoniae in Carotid Artery Atherosclerosis: A Comparison of Its Presence in Atherosclerotic Plaque, Healthy Vessels, and Circulating Leukocytes From the Same Individuals
Prager et al.
Stroke 2002;33:2756-2761.
ABSTRACT | FULL TEXT  

Chlamydia pneumoniae Seropositivity Is Associated With Increased Plasma Levels of Soluble Cellular Adhesion Molecules in Community-Dwelling Subjects: The Shimanami Health Promoting Program (J-SHIPP) Study
Kohara et al.
Stroke 2002;33:1474-1479.
ABSTRACT | FULL TEXT  

Stroke Prevention Therapy Beyond Antithrombotics: Unifying Mechanisms in Ischemic Stroke Pathogenesis and Implications for Therapy: An Invited Review
Gorelick
Stroke 2002;33:862-875.
ABSTRACT | FULL TEXT  

Case 37-2001- A 76-Year-Old Man with Fever, Dyspnea, Pulmonary Infiltrates, Pleural Effusions, and Confusion
Yawetz and Mark
NEJM 2001;345:1627-1634.
FULL TEXT  

Diabetic Foot Ulcers and Chlamydia pneumoniae: Innocent Bystander or Opportunistic Pathogen?
King et al.
Arch Dermatol 2001;137:671-672.
FULL TEXT  

Enhanced Progression of Early Carotid Atherosclerosis Is Related to Chlamydia pneumoniae (Taiwan Acute Respiratory) Seropositivity
Sander et al.
Circulation 2001;103:1390-1395.
ABSTRACT | FULL TEXT  

Search for Chlamydia pneumoniae genes and their expression in atherosclerotic plaques of carotid arteries
VALASSINA et al.
J Med Microbiol 2001;50:228-232.
ABSTRACT | FULL TEXT  

CD8+ T cells recognize an inclusion membrane-associated protein from the vacuolar pathogen Chlamydia trachomatis
Fling et al.
Proc. Natl. Acad. Sci. USA 2001;98:1160-1165.
ABSTRACT | FULL TEXT  

ICAM-1 Deficiency Reduces Atherosclerotic Lesions in Double-Knockout Mice (ApoE-/-/ICAM-1-/-) Fed a Fat or a Chow Diet
Bourdillon et al.
Arterioscler. Thromb. Vasc. Bio. 2000;20:2630-2635.
ABSTRACT | FULL TEXT  

Oxidized Lipoproteins and Infectious Agents : Are They in Collusion to Accelerate Atherogenesis?
Hajjar
Arterioscler. Thromb. Vasc. Bio. 2000;20:1421-1422.
FULL TEXT  

Chlamydia pneumoniae and Chlamydial Heat Shock Protein 60 Stimulate Proliferation of Human Vascular Smooth Muscle Cells via Toll-Like Receptor 4 and p44/p42 Mitogen-Activated Protein Kinase Activation
Sasu et al.
Circ. Res. 2001;89:244-250.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.